Archives: Agenda

• Why digital transformation in pharma often stalls despite strong tools and investments
• Evidence-based insights showing that value depends on governance, integration maturity, and work design—not technology alone
• A clear, executive-level blueprint explaining what foundations must be in place before digital initiatives can scale sustainably and compliantly
• Practical guidance for leaders to move from isolated digital pilots to end-to-end, routinised digital operations

• Assessing current geopolitical situations and their effect and potential effect on global cold chain logistics
• Crisis management: developing strategies to cope with sudden unexpected logistical constraints
• Navigating trade restrictions, sanctions and export controls impacting clinical and commercial pharma
• Adapting route planning, carrier selection and packaging strategies in response to volatility
• Strengthening supply chain resilience through diversification and proactive scenario planning

MODERATOR

Chris Wallace, Head of Distribution EMEA, Argenx

• IOT and Technology Evolution
• From Reactivity to Proactively saving shipments.
• AI in predictability – The Next frontier

The high cost and significant wastage of rescue medication or comparators represent one of the most persistent financial drains in clinical trials. Traditional sourcing models often force an impossible choice between supply continuity and cost control. Learn from this practical case study, moving beyond theory to showcase a hybrid sourcing strategy that directly tackles this challenge

• Implementing a hybrid model: Discovering how to blend different sourcing methods to minimize waste and cost for expensive rescue medications
• Balancing cost vs. risk: Analyzing strategies that combine transparent pricing and supply chain visibility with robust contingency plans for shortages
• Mastering global partner oversight: Discussing best practices for managing sourcing partners to maintain iron-clad compliance and protocol alignment across diverse regulatory regions
• Building a resilient supply chain: Learning from a real-world case study how to design a sourcing plan that scales with your trial’s size and location, ensuring quality and consistency from start to finish

Moderator: Sonnika Lamont, Senior Analyst, GlobalData

• Breaking down silos to include clinical supply in other departmental discussions earlier
• Bridging the gap between clinical supply, CMC, quality, clinical operations and other stakeholders
• Utilizing robust relationships to be better prepared when running into problems conducting trials
• Increasing the resilience of your trial through succinct collaboration

• Sanofi’s IRT transformation journey, highlighting key challenges in clinical supply and technology delivery and how IRT functions as a core system to enable a scalable and resilient supply strategy.
• Practical examples of how Sanofi leverages tailored IRT functionalities, advanced features, and specific integrations to optimize drug supply, enhance visibility, and drive operational efficiency.
• How joint planning and strong partnership resulted in continued innovation and measurable improvements supporting Sanofi’s portfolio growth.